AKRO - Akero Therapeutics, Inc. -  [ ]

Ticker Details
Akero Therapeutics, Inc.
IPO Date: July 17, 2019
Sector: Healthcare
Industry: Biotech
Market Cap: $4.5B
Activated in VL: False
Average Daily Range
Avg Daily Range: $0.76 | 2.76%
Avg Daily Range (30 D): $0.14 | 0.26%
Avg Daily Range (90 D): $0.25 | 0.52%
Institutional Daily Volume
Avg Daily Volume: .59M
Avg Daily Volume (30 D): M
Avg Daily Volume (90 D): 1.59M
Trade Size
Avg Trade Size (Sh.): 69
Avg Trade Size (Sh.) (30 D): 433
Avg Trade Size (Sh.) (90 D): 125
Institutional Trades
Total Institutional Trades: 3,244
Avg Institutional Trade: $2.98M
Avg Institutional Trade (30 D): $3.6M
Avg Institutional Trade (90 D): $3.79M
Avg Institutional Trade Volume: .08M
Avg Institutional Trades (Per Day): 2
Market Closing Trades
Avg Closing Trade: $4.43M
Avg Closing Trade (30 D): $84.18M
Avg Closing Trade (90 D): $9.51M
Avg Closing Volume: 126.07K
 
News
Nov 20, 2025 @ 9:57 PM
Halper Sadeh LLC Encourages SEE, AXTA, SEMR, AKRO ...
Source: Halper Sadeh Llc
Nov 18, 2025 @ 1:30 AM
SHAREHOLDER ALERT: The M&A Class Action Firm Conti...
Source: Juan Monteverde
Nov 7, 2025 @ 6:40 PM
Halper Sadeh LLC Encourages JAMF, CADE, AKRO, GES ...
Source: Halper Sadeh Llc
Nov 6, 2025 @ 10:50 PM
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Inve...
Source: Brodsky & Smith
Nov 5, 2025 @ 6:30 AM
Novo Nordisk's sales increased by 12% in Danish kr...
Source: Novo Nordisk
Financials
  TTM Q3 2025 Q2 2025
Basic EPS $-3.74 $-.99 $-.86
Diluted EPS $-3.75 $-.99 $-.86
Revenue
Gross Profit
Net Income / Loss $-292.82M $-81.57M $-70.51M
Operating Income / Loss $-330.02M $-90.24M $-80.87M
Cost of Revenue
Net Cash Flow $-140.03M $-44.42M $34.53M
PE Ratio